Synthesis and Biological Activity of Fullerenols with Various Contents of Hydroxyl Groups

Pharmaceutical Chemistry Journal

Volumn 47, Issue 2, 2013, Pages 87-91

  Eropkin, M Yu ^a   Melenevskaya, E Yu ^b   Nasonova, K V ^b   Bryazzhikova, T S ^a   Eropkina, E M ^a   Danilenko, D M ^a   Kiselev, O I ^a  

^a Research Institute of Influenza Ministry of Healthcare of the Russian Federation   (Russian Federation)

^b INSTITUTE OF MACROMOLECULAR COMPOUNDS   (Russian Federation)

Author keywords

antiviral activity; cell cultures; fullerenols; UVA protective effect

Indexed keywords

FULLERENE DERIVATIVE; HYDROXYL GROUP;

ARTICLE; BIOLOGICAL ACTIVITY; DRUG SYNTHESIS;

EID: 84879204056     PISSN: 0091150X     EISSN: 15739031     Source Type: Journal    
DOI: 10.1007/s11094-013-0901-x     Document Type: Article

References (20)

1. L. Piotrovsky, M. Eropkin, E. Eropkina, et al., in: Medicinal Chemistry and Pharmacological Potential of Fullerenes and Carbon Nanotubes, F. Cataldo, T. da Ros (eds.), Springer, (2008), pp. 139 - 155.
2. R. Partha, J. L. Conyers, Int. J. Nanomed., 4, 261 - 275 (2009).
3. L. B. Piotrovsky, O. I. Kiselev, Fullerenes in Biology [in Russian], Rostok, St. Petersburg (2006).
4. J. Mrdanovic, S. Solajic, V. Bogdanovic, et al., Mutat. Res., 680(1 - 2), 25 - 30 (2009).
5. J.-J. Yin, L. Fang, P. P. Fu, et al., Biomaterials, 30, 611 - 621 (2009).
6. S. M. Mirkov, A. N. Djordjevic, N. L. Andric, et al., Nitric Oxide, 11(2), 201 - 207 (2004).
7. S. Trajkovic, S. Dobric, V. Jacevic, et al., Colloids Surf. B: Biointerfaces, 58(1), 39 - 43 (2007).
8. F. Jiao, Y. Qu,W. Li, et al., Carbon, 48(8), 2231 - 2243 (2010).
9. Y. Saitoh, A. Miyanishi, H. Mizuno, et al., J. Photochem. Photobiol., B, doi: 10.1016/j.jphotobiol.2010.09.006 (2010).
10. H.-S. Lai, Y. Chen, W.-J. Chang, L.-Y. Chiang, Transplant. Proc., 32, 1272 - 1274 (2000).
11. L. B. Piotrovsky, K. N. Kozeletskaya, N. A. Medvedeva, et al., Vopr. Virusol., No. 3, 38 - 42 (2001).
12. V. V. Zarubaev, I. Belousova, V. Rylkov, et al., in: Medicinal Chemistry and Pharmacological Potential of Fullerenes and Carbon Nanotubes, F. Cataldo, T. da Ros (eds.), Springer, (2008), pp. 107 - 122.
13. N. I. Nosik, N. G. Kondrashina, A. Yu. Grigor'eva, et al., Vopr. Virusol., No. 1, 15 - 18 (2009).
14. D. A. Nosik, N. K. Lyalina, L. B. Kalnine, et al., Vopr. Virusol., No. 5, 41 - 43 (2009).
15. B. M. Mikawa, H. Kato, M. Okumura, et al., Bioconjugate Chem., 12, 510 - 514 (2001).
16. C. Y. Chen, G. M. Xing, J. X. Wang, et al., Nano Lett., 5(10), 2050 - 2057 (2005).
17. R. Singh, T. H. Goswami, J. Organomet. Chem., 693, 2021 - 2032 (2008).
18. R. Clothier, G. Starzec, L. Pradel, et al., ATLA, Altern. Lab. Anim., 30, 493 - 504 (2002).
19. T. Mosmann, J. Immunol. Methods, 65(1), 55 - 63 (1983).
20. M. Yu. Eropkin, T. M. Gudkova, N. I. Konovalova, et al., Eksp. Klin. Farmakol., 70(5), 33 - 37 (2007).